Ruicci, K. M., Deng, Y., Xiao, T., Eskander, A., Goldstein, D., Mete, O., . . . Ma, L. X. Real-world treatment outcomes and clinicopathologic and molecular determinants of response to first-line lenvatinib in patients with advanced follicular cell-derived thyroid cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationRuicci, Kara M., et al. Real-world Treatment Outcomes and Clinicopathologic and Molecular Determinants of Response to First-line Lenvatinib in Patients with Advanced Follicular Cell-derived Thyroid Cancer. Nature Portfolio.
MLA (9th ed.) CitationRuicci, Kara M., et al. Real-world Treatment Outcomes and Clinicopathologic and Molecular Determinants of Response to First-line Lenvatinib in Patients with Advanced Follicular Cell-derived Thyroid Cancer. Nature Portfolio.